Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve Board Meeting ....
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krebs Biochemicals & Industries Ltd has informed the stock exchanges that its Board of Directors will meet on Monday, February 9, 2026. The main agenda is to consider and approve the unaudited financial results for the third quarter (Q3) and nine months ended December 31, 2025. The company also reminded that the trading window for insiders remains closed since the close of business on December 31, 2025, and will reopen 48 hours after the results are declared. This is a standard quarterly results announcement filing under SEBI listing regulations.
This is a routine regulatory filing ahead of the Q3 FY26 earnings announcement. Investors should watch for the actual results on or after February 9, 2026. The stock may see some volatility around the results date depending on the numbers reported.